Table 1:
Characteristic | Perforation Group | PVP Group | P Value |
---|---|---|---|
No. of patients | 58 | 50 | |
Mean age (yr) (range) | 76.7 ± 4.2 | 77.5 ± 8.4 | .35 |
No. of women (%) | 48 | 42 | |
Preop. VAS score | 7.0 ± 2.1 | 7.0 ± 1.4 | .82 |
Mean duration of symptoms (day) | 127.8 ± 105 | 145.3 ± 112 | .68 |
Posterior destruction of VB | (+) 19 | (+) 10 | .09 |
(–) 39 | (–) 40 | ||
No. of patients with preexisting VCFs | (+) 34 | (+) 31 | .42 |
(–) 24 | (–) 19 | ||
Distribution of treated VCFs | T7-L5 | T6-L4 | |
Presence of kyphotic change | (+) 15 | (+) 18 | .15 |
(–) 43 | (–) 32 | ||
Preop. vertebral percentage of compression (%) | 45.9 ± 29.7 | 42.5 ± 14.2 | .64 |
Preop. intravertebral cleft on MRI | (+) 30 | (+) 15 | .02 |
(–) 28 | (–) 35 | ||
Communication of puncture holes | (+) 15 | ||
(–) 43 |
Note:—preop indicates preoperative; VB, vertebral body.
Statistical analyses were performed with the Mann-Whitney U test or the Fisher exact test.